Neuromod Appoints Joe Ghiz and Shannon Basham to Boost Sales Strategy and Tinnitus Treatment Access

Neuromod's Strategic Leadership Changes to Enhance Tinnitus Solutions

Neuromod Devices is taking significant steps in bolstering its commercial efforts with the recent appointments of Joe Ghiz as Chief Commercial Officer and Shannon Basham as Vice President of Channel Development. This leadership shift aligns with Neuromod’s mission to expand the reach of Lenire, an innovative tinnitus treatment device, in a growing global market.

Who are the New Leaders?

Joe Ghiz

Joe Ghiz joins Neuromod with a wealth of experience in commercial leadership from notable positions in companies like Align Technology and Johnson & Johnson. With a strong background in driving growth and market expansion, Ghiz brings a fresh perspective that is crucial for Neuromod at this juncture of its growth.

At Align Technology, renowned for its Invisalign brand, Ghiz played an instrumental role in redefining the orthodontic landscape through the introduction of transparent aligners. These innovations significantly transformed how orthodontics is practiced, contributing to Align's impressive valuation of around $10 billion.

In his new role at Neuromod, Ghiz will be responsible for shaping and advancing the company’s global sales strategy as it seeks to address the needs of over 740 million individuals worldwide suffering from tinnitus. Ghiz expressed his enthusiasm: "I am looking forward to being part of such a critical phase of growth at Neuromod. Lenire has changed the lives of thousands suffering from tinnitus and has the potential to transform the treatment landscape."

Shannon Basham

Joining Ghiz is Shannon Basham, who has over two decades of experience in the hearing aid industry. Before Neuromod, she was a Senior Director at Sonova Group, where she led audiology strategies for the Phonak and Unitron brands. Basham’s expertise in developing market-oriented strategies will enhance Neuromod's initiatives in channel development, ensuring that Lenire reaches those who need it.

Basham stated, "My extensive experience in audiology aligns perfectly with Neuromod's innovative approach to tinnitus treatment. I am excited to contribute to expanding access to Lenire."

Neuromod's Vision for Tinnitus Treatment

The appointments of Ghiz and Basham are timely as Neuromod prepares for rapid growth. Chief Executive Officer Dr. Ross O'Neill emphasized the importance of their expertise at this pivotal moment: “We are eager to welcome Joe Ghiz to the Neuromod team at a time when robust clinical evidence, worldwide regulatory approvals, and widespread commercial acceptance enable our company to quickly expand.”

Lenire is a groundbreaking treatment that utilizes bimodal neuromodulation to mitigate the symptoms of tinnitus effectively. This innovative device combines acoustic stimulation with a tongue interface, dubbed Tonguetip®, allowing patients to administer treatment comfortably from home, enhancing patient adherence and satisfaction.

Clinical Efficacy and Future Prospects

Neuromod has invested heavily in clinical studies, validating Lenire's safety and effectiveness. These large-scale studies affirm that the device's bimodal neuromodulation approach can significantly alleviate tinnitus symptoms. With CE-mark certification and a De Novo Approval Grant from the FDA, Lenire stands out in the field of tinnitus therapies. It is currently available in the U.S., Canada, Europe, and Australia, and is recognized as a potential treatment option by the U.S. Department of Veterans Affairs.

As Joe Ghiz and Shannon Basham settle into their new roles, their leadership is expected to propel Neuromod to new heights, making significant strides in not only expanding the company’s commercial presence but also improving the lives of many individuals suffering from tinnitus globally. Neuromod is poised to redefine tinnitus treatment with its commitment to innovation and clinical excellence, guided by the expertise of its new leadership team.

For further information about Neuromod and its remarkable tinnitus treatment, visit www.neuromod.com.